• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Quick Take: Genomic characterization of metastatic breast cancers

byDonna LeetandAliya Ramjaun
May 31, 2019
in Chronic Disease, Obstetrics, Oncology, Preclinical
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

RELATED REPORTS

Screening with digital breast tomosynthesis vs mammography associated with significantly lower risk of advanced breast cancer among women with extremely dense breasts at high risk of breast cancer

Trastuzumab deruxtecan is a treatment option for pre-treated HER2-low metastatic breast cancer

#VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer

Several late-stage cancers have been shown to acquire genomic alterations during disease evolution. In patients with breast cancer, 20% of metastatic tumors develop ESR1 mutations during endocrine therapy. However, the full spectrum of possible genomic alterations in metastatic breast cancer has not been described. In this study, the tumors of 617 patients with metastatic breast cancer (mBC) were sequenced using whole-exome sequencing to investigate the potential clinical relevance of all enriched somatic alterations. At baseline, 381 patients had hormone receptor positive (HR+)/HER2- breast cancer, 182 had triple-negative breast cancer, and 30 had HER2+ breast cancer. Researchers found that 21 genes were significantly mutated across the cohort or in at least one clinical subgroup (q<0.1). To determine which genes were differentially altered in mBC versus early breast cancer (eBC), the frequency of alterations observed in the study was compared to that in the Cancer Genome Atlas (TCGA). In patients with HR+/HER2- breast cancer, 9 driver genes were more frequently mutated in mBCs: TP53 (29%), ESR1 (22%), GATA3 (18%), KMT2C (12%) NCOR1 (8%), AKT1 (7%), NF1 (7%), RIC8A (4%) and RB1 (4%). Mutations in TP53, RB1, or NF1 were associated with a poor outcome in HR+/HER2- mRBCs (HR 2.20, 95% CI 1.57 to 3.07, p<0.001; HR 2.37, 95% CI 1.15 to 4.81, p=0.019; HR 1.91, 95% CI 1.09 to 3.35, p=0.024, respectively). Moreover, copy number analysis revealed that 18 amplicons were more frequently observed in HR+/HER2- mBCs than in eBCs. An analysis of mutational signatures demonstrated that HR+/HER2- mBCs exhibited an increase in 5 mutational signatures as compared to HR+/HER2- eBCs (p<0.001), and a decrease in 1 mutational signature. In multivariate analysis, 3 of the mutational signatures that were increased in mBCs, S10 (HR 1.67, 95% CI 1.20 to 2.32, p=0.002), S13 (HR 1.80, 95% CI 1.28 to 2.53, p=0.001) and S17 (HR 1.52, 95% CI 1.09 to 2.14, p=0.015), were associated with a poor outcome. Finally, mBCs showed an increase in mutational burden and clonal diversity compared to eBCs. In summary, this study identified several somatic alterations associated with poor outcomes in metastatic breast cancer, suggesting that early identification of these variants could inform therapy selection and may improve prognostication in these patients.

Click to read the study in Nature

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Breast Cancerhormone receptor (HR)human epidermal growth factor receptor 2 (HER2)metastatic breast cancerwhole-exome sequencing
Previous Post

Quick Take: Robot assisted training for the upper limb after stroke (RATULS)

Next Post

The SPICE III trial: dexmedetomidine is rarely effective as a sole agent for sedation of ICU patients

RelatedReports

2 Minute Medicine Rewind March 4, 2019
Chronic Disease

Screening with digital breast tomosynthesis vs mammography associated with significantly lower risk of advanced breast cancer among women with extremely dense breasts at high risk of breast cancer

June 16, 2022
Age and number of islet autoantibodies associated with diabetes risk
Oncology

Trastuzumab deruxtecan is a treatment option for pre-treated HER2-low metastatic breast cancer

June 13, 2022
#VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer
StudyGraphics

#VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer

May 18, 2022
Wellness

Several factors influence health programs conducted in the African American Church

May 18, 2022
Next Post

The SPICE III trial: dexmedetomidine is rarely effective as a sole agent for sedation of ICU patients

#VisualAbstract: Diabetes-Related Emotional Distress Over Time

#VisualAbstract: Diabetes-Related Emotional Distress Over Time

Increased number of daily steps linked with decreased mortality in older women

Increased number of daily steps linked with decreased mortality in older women

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Vitamin and mineral supplementation associated with minimal to no benefit in the primary preventing of cardiovascular disease and cancer – US Preventative Services Task Force
  • RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection
  • Incidence of Kawasaki disease found to be lower during the COVID-19 pandemic in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.